The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2021

Filed:

Aug. 12, 2016
Applicants:

Beihao Stem Cell and Regenerative Medicine Research Institute Co., Ltd., Guangdong, CN;

Peking University, Beijing, CN;

Hong Guan Ltd., Bejing, CN;

Inventors:

Hongkui Deng, Beijing, CN;

Yang Yang, Beijing, CN;

Bei Liu, Beijing, CN;

Jun Xu, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0735 (2010.01); C12N 15/873 (2010.01); C12N 5/073 (2010.01); A61K 35/545 (2015.01); C12N 5/074 (2010.01); C07K 16/38 (2006.01); C07K 16/40 (2006.01); A01K 67/027 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0696 (2013.01); A01K 67/0271 (2013.01); A61K 35/545 (2013.01); C07K 16/38 (2013.01); C07K 16/40 (2013.01); C12N 5/0605 (2013.01); C12N 5/0606 (2013.01); C12N 15/873 (2013.01); A01K 2207/12 (2013.01); A01K 2217/00 (2013.01); A01K 2227/105 (2013.01); C12N 2501/15 (2013.01); C12N 2501/20 (2013.01); C12N 2501/235 (2013.01); C12N 2501/2306 (2013.01); C12N 2501/237 (2013.01); C12N 2501/2311 (2013.01); C12N 2501/2327 (2013.01); C12N 2501/2331 (2013.01); C12N 2501/603 (2013.01); C12N 2501/999 (2013.01); C12N 2503/02 (2013.01); C12N 2510/00 (2013.01);
Abstract

Factors for extending the ability of isolated pluripotent stem cells to generate extraembryonic lineages in vivo, following in vitro culture, herein, chemical extenders of pluripotency (CEP). Methods of extending the ability of a pluripotent cell to generate embryonic and extraembryonic lineages. The cell to be reprogrammed is contacted with effective amounts of the CEPs for a sufficient period of time to reprogram the cell into a chemically induced extended pluripotent cell (ciEPSC). ciEPSC are identified as an extended pluripotent cell based on properties including: (i) morphologically and (ii) functionally for example, based on their ability contribute to both TE and ICM, in vivo. The ciEPSCs can be cultured or induced to differentiate into cells of a desired type, and used in a number of applications, including but not limited to cell therapy and tissue engineering.


Find Patent Forward Citations

Loading…